According to reports from the Singapore Economic Development Board (EDB), Milliken & Company (Spartanburg, S.C.) announced the opening of its new manufacturing facility in Singapore. This strategic capacity expansion is Milliken’s first chemical plant in Asia and grows the company’s manufacturing footprint to meet increasing demand for advanced material solutions in the region.
The new operation is Milliken’s latest investment in Encapsys’ microencapsulation technology and provides greater flexibility and speed in supporting customer needs. Acquired by Milliken in 2021, Encapsys is a world leader in microencapsulation, with more than 70 years of pioneering patented solutions.
“This new facility is a testament to our dedication to meet growing demand in this dynamic region,” said Ed Zhao, SVP and Asia Managing Director, Milliken.
“Milliken’s decision to establish its first Asian chemical plant here reflects its confidence in Singapore’s position as a strategic hub for specialty chemicals in the region. The new plant’s advanced manufacturing capabilities will strengthen our chemicals ecosystem and meet growing customer needs in areas such as consumer goods and healthcare. We continue to welcome like-minded partners such as Milliken to tap on Singapore’s capabilities and connectivity, to create cutting-edge material solutions for the world,” Kelly Lai, Vice President, Chemicals and Material, EDB.